Save your place

Sign in to WhoBought

Please try again later.

Invesco's Rhythm Pharmaceuticals, Inc. (RYTM) position

Yes: as of Q1 2026, Invesco holds 364K shares of RYTM worth an amount we cannot price (0.0% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
an amount we cannot price
Shares held
364K
% of portfolio
0.0%
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

RYTM price vs Invesco's position

Dates
$95$100$105$110← Earlier —11 purchases, 6 sells
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +73K +25.1% 364K May 12, 2026
Q4 2025 Added +148K +102.8% 291K Feb 19, 2026
Q3 2025 Added +75K +108.3% 144K Nov 13, 2025
Q2 2025 Reduced −193K −73.7% 69K Aug 13, 2025
Q1 2025 Reduced −41K −13.5% 262K May 12, 2025
Q4 2024 Added +38K +14.5% 303K Feb 13, 2025
Q3 2024 Reduced −12K −4.4% 264K Nov 12, 2024
Q2 2024 Added +188K +213.7% 277K Aug 13, 2024
Q1 2024 Reduced −48K −35.0% 88K May 14, 2024
Q4 2023 Added +107K +378.4% 136K Feb 13, 2024
Q3 2023 Added +98 +0.3% 28K Nov 13, 2023
Q2 2023 New +28K 28K Aug 11, 2023
Q4 2022 New +334K 334K Feb 13, 2023
Q1 2022 Reduced −8K −31.9% 17K May 16, 2022
Q4 2021 Reduced −3K −11.3% 24K Feb 14, 2022
Q3 2021 Added +2K +8.0% 27K Nov 15, 2021
Q2 2021 Added +8K +47.1% 25K Aug 17, 2021
Q1 2021 First covered 17K May 17, 2021
Data through Q1 2026 · filed May 12, 2026
18 grouped rows from 18 quarters

More Invesco positions

Common questions

Does Invesco own RYTM?

Yes. As of Q1 2026, Invesco disclosed 364K shares of RYTM, worth an amount we cannot price. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Invesco buy RYTM?

Invesco held RYTM since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Invesco sell RYTM?

The quarter-by-quarter table above shows each sale and reduction Invesco disclosed in RYTM. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of RYTM does Invesco own?

Invesco disclosed 364K shares of RYTM as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Invesco pay for RYTM?

Invesco began building the RYTM position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.